Could a home device help stroke survivors walk better?

NCT ID NCT05849532

First seen Jun 26, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tests whether using a home-based electrical stimulation device, combined with specific exercises, can help people with chronic stroke improve their walking, balance, and mobility. Thirty adults who had a stroke more than six months ago will use the device during training sessions at home over 12 weeks. The goal is to see if this approach is safe, practical, and effective for everyday recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Functional Electrical Stimulation (FES) device
What this could lead to
If successful, this could offer a practical home-based therapy to improve walking and balance for people with chronic stroke, reducing fall risk and enhancing daily function.
What could go wrong
This is a small early feasibility study with only 30 participants, so results may not apply to everyone. The home-based setup relies on technology and internet access, which could limit participation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Illinois at Chicago

    RECRUITING

    Chicago, Illinois, 60612-4225, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.